Jump to content

Harrison Stafford

Legacy Members
  • Posts

    2852
  • Joined

  • Last visited

Reputation

3593 Surly 10%

2 Followers

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. Have had no alcohol since August 25th. The desire to drink hasn’t dissipated entirely, but it’s no longer front and center all day every day. I’m an old and need no outside help to compromise my balance, coordination, and reaction times. Now, I drink nonalcoholic beer and have tried too many of them…most of which were repulsive. Heineken Zero is good. In fact, I like the nonalcoholic offering more than the regular beer. Guinness 0 is good. The best tasting NA beer I’ve found is Deschutes Brewery Kernza Golden Brew. Total Wine carries it. Should you venture down the path of NA beers, start with these three. You’ll save your taste buds and your money. My wife thinks it’s hilarious that I have a beer before going to bed (like it’s going to relax me). At least once a week, she will tell me how much nicer it is to wake up to a husband who’s lucid in the morning. In retrospect, I don’t know how she tolerated me when I was drinking. Each morning, the first thing I do is thank God for having made it another 24 hrs without alcohol and, then, I think of what I can do to make it up to my wife who has stood by me during the biggest battle of my life. I’m so not deserving of her. The Lord looks out for fools.
  2. The kid strikes out the side.
  3. First start in the bigs. Let’s see if he settles in now.
  4. What? No Goose Gossage?
  5. https://www.gurufocus.com/news/2764363/immunitybio-to-host-key-opinion-leader-and-investor-meeting-to-provide-updates-on-clinical-programs-and-anktiva-commercial-launch#:~:text=ImmunityBio%2C Inc. (NASDAQ,company’s research programs. IBRX hosting Investor Day April 15th. If the approvals come, the revenues will too, and I think they will be huge. Anktiva can rescue if not replace Keytruda which made Merck $30 billion in sales last year.
  6. ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor Apr. 08, 2025 7:30 AM ETImmunityBio, Inc. (IBRX) CULVER CITY, Calif.--(BUSINESS WIRE)-- ImmunityBio, Inc. (IBRX) (NASDAQ: IBRX), a leading immunotherapy company, today announced that it has executed financing to provide further working capital and support its ongoing business operations. The Company entered into a securities purchase agreement for a registered direct offering with a single institutional investor (Armistice Capital), providing for the issuance of common stock of ImmunityBio as well as warrants for the purchase of additional shares of common stock of ImmunityBio that is expected to result in gross proceeds at closing of approximately $75 million before deducting any offering-related expenses, subject to customary closing conditions. If fully exercised, the warrants could result in additional gross proceeds of up to approximately $90 million. Funding doesn’t appear to be an issue w/IBRX.
  7. The UH defense will make life more difficult for Walter Clayton than any team he’s faced in the tournament. I also like UH‘s front line vs. Florida’s big men.
  8. Don’t you dare screw with Monday night!
  9. Duke had not been tested like UH. They failed.
  10. Finishing 5th out of 67 entries is nothing to sneeze at. If UH wins, kudos to you, brother.
  11. I get plenty of shit wrong, but I got this one right.
×
×
  • Create New...